These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6768170)

  • 21. The human complement system.
    Volanakis JE
    J Oral Pathol; 1975; 4(4):195-221. PubMed ID: 811779
    [No Abstract]   [Full Text] [Related]  

  • 22. Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.
    Veerhuis R; van der Valk P; Janssen I; Zhan SS; Van Nostrand WE; Eikelenboom P
    Virchows Arch; 1995; 426(6):603-10. PubMed ID: 7655742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypochlorite-induced alterations to canine serum complement.
    Boyer JT; Wyde P; Bier M
    Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis.
    Kim Y; Friend PS; Dresner IG; Yunis EJ; Michael AF
    Am J Med; 1977 May; 62(5):765-71. PubMed ID: 860727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement factors and acute phase reactants in the Guillain-Barré syndrome.
    Tönnessen TI; Nyland H; Aarli JA
    Eur Neurol; 1982; 21(2):124-8. PubMed ID: 6920298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemolytic complement in tears.
    Mondino BJ; Zaidman GW
    Ophthalmic Res; 1983; 15(4):208-11. PubMed ID: 6634056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract]   [Full Text] [Related]  

  • 30. Subtotal C4 deficiency and SLE-like disease.
    Irestedt M; Svensson A; Månsson T
    Acta Derm Venereol; 1986; 66(1):67-70. PubMed ID: 2424221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of anticomplementary substances on properdin in normal and C2-deficient sera.
    McLean RH; Townsend K; Michael AF
    Clin Exp Immunol; 1975 Mar; 19(3):435-44. PubMed ID: 1204244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formation of EAC142 and EAC1423 with macrophage culture supernatant containing the secreted complement components C1 to C3.
    Brade V; Beuscher HU
    Immunobiology; 1984 Mar; 166(2):177-89. PubMed ID: 6724636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The bovine complement system.
    Linscott WD; Triglia RP
    Adv Exp Med Biol; 1981; 137():413-30. PubMed ID: 7331946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement component profiles in urticaria, dermatitis herpetiformis, and alopecia areata.
    Berrens L; Jankowski E; Jankowski-Berntsen I
    Br J Dermatol; 1976 Aug; 95(2):145-52. PubMed ID: 952750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement studies in children with treated coeliac disease after gluten challenge.
    Bosch C; Becker M; Rotthauwe HW; Opferkuch W
    Eur J Pediatr; 1980 Aug; 134(2):145-8. PubMed ID: 6904300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
    Gigli I; Koethe S; Austen KF
    Clin Immunol Immunopathol; 1975 Jul; 4(2):189-98. PubMed ID: 1170051
    [No Abstract]   [Full Text] [Related]  

  • 37. The functional significance of complement.
    Fearon DT; Ruddy S; Knostman JD; Carpenter CB; Austen KF
    Adv Nephrol Necker Hosp; 1974; 4():15-35. PubMed ID: 4219991
    [No Abstract]   [Full Text] [Related]  

  • 38. [Familial Mediterranean fever, complement, cryofibrinogen, colchicine (author's transl)].
    Wautier JL; Mosesson M; Dervichian M; Cattan D
    Ann Med Interne (Paris); 1981; 132(7):472-4. PubMed ID: 7337322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of collagen with serum complement: inhibition of complement-mediated hemolysis.
    Takahashi M; KawachiTakahashi S; Matsuura M
    Int Arch Allergy Appl Immunol; 1975; 48(5):642-52. PubMed ID: 166040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway.
    Kapil A; Sharma S
    J Pharm Pharmacol; 1994 Nov; 46(11):922-3. PubMed ID: 7897600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.